Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

NAMPT (visfatin) and AKT1 genetic variants associate with myocardial infarction.

Leander K, Gigante B, Silveira A, Vikström M, Hamsten A, Högberg J.

Clin Chim Acta. 2012 Apr 11;413(7-8):727-32. doi: 10.1016/j.cca.2012.01.002. Epub 2012 Jan 9.

PMID:
22251423
2.

Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis.

García-Bermúdez M, González-Juanatey C, Rodríguez-Rodríguez L, Miranda-Filloy JA, Perez-Esteban S, Vazquez-Rodriguez TR, Castañeda S, Balsa A, Fernández-Gutierrez B, Llorca J, González-Alvaro I, Martín J, González-Gay MA.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4):681-8. Epub 2011 Aug 31.

PMID:
21906432
3.

Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels.

Gigante B, Vikström M, Meuzelaar LS, Chernogubova E, Silveira A, Hooft FV, Hamsten A, de Faire U.

Thromb Haemost. 2009 May;101(5):943-53.

PMID:
19404549
4.

Association between ESR2 genetic variants and risk of myocardial infarction.

Domingues-Montanari S, Subirana I, Tomás M, Marrugat J, Sentí M.

Clin Chem. 2008 Jul;54(7):1183-9. doi: 10.1373/clinchem.2007.102400. Epub 2008 May 16.

5.

Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy.

Luizon MR, Belo VA, Palei AC, Amaral LM, Lacchini R, Sandrim VC, Duarte G, Cavalli RC, Tanus-Santos JE.

Hypertens Res. 2015 May;38(5):361-6. doi: 10.1038/hr.2015.15. Epub 2015 Feb 26.

PMID:
25716650
6.

The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity.

Belo VA, Luizon MR, Lacchini R, Miranda JA, Lanna CM, Souza-Costa DC, Tanus-Santos JE.

Int J Obes (Lond). 2015 Jan;39(1):130-5. doi: 10.1038/ijo.2013.173. Epub 2013 Sep 12.

PMID:
24100423
7.

The -589C>T polymorphism in the interleukin-4 gene (IL-4) is associated with a reduced risk of myocardial infarction in young individuals.

Paffen E, Medina P, de Visser MC, van Wijngaarden A, Zorio E, Estellés A, Rosendaal FR, España F, Bertina RM, Doggen CJ.

J Thromb Haemost. 2008 Oct;6(10):1633-8. doi: 10.1111/j.1538-7836.2008.03096.x. Epub 2008 Jul 25.

8.

Association of interleukin 8 with myocardial infarction: results from the Stockholm Heart Epidemiology Program.

Velásquez IM, Frumento P, Johansson K, Berglund A, de Faire U, Leander K, Gigante B.

Int J Cardiol. 2014 Mar 1;172(1):173-8. doi: 10.1016/j.ijcard.2013.12.170. Epub 2014 Jan 9.

PMID:
24462138
9.

Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke.

Siegerink B, Rosendaal FR, Algra A.

J Thromb Haemost. 2009 Mar;7(3):385-90. doi: 10.1111/j.1538-7836.2008.03266.x.

10.

Interaction between MMP-9 gene polymorphisms and smoking in relation to myocardial infarction in a Uighur population.

Wang L, Ma YT, Xie X, Yang YN, Fu ZY, Li XM, Liu F, Huang Y, Ma X, Chen BD, Yuan S, Sun MH, Peng X, Wang BZ.

Clin Appl Thromb Hemost. 2012 Jan-Feb;18(1):72-8. doi: 10.1177/1076029611412365. Epub 2011 Jul 6.

PMID:
21733941
11.

A rare variant in the visfatin gene (NAMPT/PBEF1) is associated with protection from obesity.

Blakemore AI, Meyre D, Delplanque J, Vatin V, Lecoeur C, Marre M, Tichet J, Balkau B, Froguel P, Walley AJ.

Obesity (Silver Spring). 2009 Aug;17(8):1549-53. doi: 10.1038/oby.2009.75. Epub 2009 Mar 19.

12.

Association of polymorphisms of BTN2A1 and ILF3 with myocardial infarction in Japanese individuals with or without hypertension, diabetes mellitus or chronic kidney disease.

Yoshida T, Kato K, Oguri M, Horibe H, Kawamiya T, Yokoi K, Fujimaki T, Watanabe S, Satoh K, Aoyagi Y, Tanaka M, Yoshida H, Shinkai S, Nozawa Y, Yamada Y.

Int J Mol Med. 2011 May;27(5):745-52. doi: 10.3892/ijmm.2011.623. Epub 2011 Feb 23.

PMID:
21347509
13.

A gain-of-function SNP in TRPC4 cation channel protects against myocardial infarction.

Jung C, Gené GG, Tomás M, Plata C, Selent J, Pastor M, Fandos C, Senti M, Lucas G, Elosua R, Valverde MA.

Cardiovasc Res. 2011 Aug 1;91(3):465-71. doi: 10.1093/cvr/cvr083. Epub 2011 Mar 22.

15.

The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study.

Juhan-Vague I, Morange PE, Frere C, Aillaud MF, Alessi MC, Hawe E, Boquist S, Tornvall P, Yudkin JS, Tremoli E, Margaglione M, Di Minno G, Hamsten A, Humphries SE; HIFMECH Study Group.

J Thromb Haemost. 2003 Nov;1(11):2322-9.

16.

Association of Nicotinamide Phosphoribosyltransferase (NAMPT) Gene Polymorphisms and of Serum NAMPT Levels with Dilated Cardiomyopathy in a Chinese Population.

Dou Q, Peng Y, Zhou B, Zhang K, Lin J, Dai X, Zhang L, Rao L.

Int J Mol Sci. 2015 Sep 15;16(9):22299-318. doi: 10.3390/ijms160922299.

19.

Significant associations of the rs2943634 (2q36.3) genetic polymorphism with adiponectin, high density lipoprotein cholesterol and ischemic stroke.

Arregui M, Fisher E, Knüppel S, Buijsse B, di Giuseppe R, Fritsche A, Corella D, Willich SN, Boeing H, Weikert C.

Gene. 2012 Feb 25;494(2):190-5. doi: 10.1016/j.gene.2011.12.009. Epub 2011 Dec 20.

PMID:
22207032
20.

PAI-1 level and the PAI-1 4G/5G polymorphism in relation to risk of non-fatal myocardial infarction: results from the Stockholm Heart Epidemiology Program (SHEEP).

Leander K, Wiman B, Hallqvist J, Sten-Linder M, de Faire U; Stockholm Heart Epidemiology Program.

Thromb Haemost. 2003 Jun;89(6):1064-71.

PMID:
12783120
Items per page

Supplemental Content

Write to the Help Desk